The prevalence of Ehlers Danlos syndrome (EDS) varies depending on the specific type. The most common type, hypermobile EDS, is estimated to affect around 1 in 5,000 individuals worldwide. Other types, such as classical EDS, vascular EDS, and others, are rarer with prevalence rates ranging from 1 in 20,000 to 1 in 200,000. EDS is a group of genetic connective tissue disorders characterized by joint hypermobility, skin fragility, and other symptoms. Early diagnosis and proper management are crucial for individuals with EDS to improve their quality of life.
Ehlers-Danlos syndrome (EDS) is a group of genetic disorders that affect the connective tissues in the body. It is estimated that EDS affects approximately 1 in every 5,000 to 20,000 individuals worldwide, making it a relatively rare condition.
There are several subtypes of EDS, each with its own prevalence rate. The most common subtype, known as hypermobile EDS (hEDS), is estimated to affect around 1 in every 5,000 individuals. Other subtypes, such as classical EDS (cEDS) and vascular EDS (vEDS), are much rarer, with prevalence rates of approximately 1 in every 20,000 to 40,000 individuals.
It is important to note that due to the variability in symptoms and the underdiagnosis of EDS, the true prevalence may be higher than currently reported. EDS can affect individuals of any gender, race, or age group.
Early diagnosis and proper management are crucial in improving the quality of life for individuals with EDS. If you suspect you or someone you know may have EDS, it is recommended to consult with a healthcare professional who can provide a comprehensive evaluation and appropriate care.